A randomized, double-blind, placebo-controlled trial of ISC 17536, an oral inhibitor of TRPA1, in patients with painful diabetic peripheral neuropathy
2010 ◽
Vol 28
(1)
◽
pp. 109-116
◽
1990 ◽
Vol 7
(4)
◽
pp. 319-323
◽
2012 ◽
Vol 97
(3)
◽
pp. 438-445
◽